Revised International Staging System Is Predictive and Prognostic for Early Relapse (<24 months) after Autologous Transplantation for Newly Diagnosed Multiple Myeloma

Sathish Gopalakrishnan,Anita D'Souza,Emma C. Scott,Raphael Fraser,Omar Davila,Nina Shah,Robert Peter Gale,Rammurti T. Kamble,Miguel Angel Diaz,Hillard M. Lazarus,Bipin N. Savani,Gerhard C. Hildebrandt,Melhem Solh,Cesar O. Freytes,Cindy Lee,Robert A. Kyle,Saad Z. Usmani,Siddhartha Ganguly,Amer Assal,Jesus G. Berdeja,Abraham S. Kanate,Binod Dhakal,Kenneth R. Meehan,Tamila L. Kindwall-Keller,Ayman Saad,Frederick L. Locke,Sachiko Seo,Taiga Nishihori,Usama Gergis,Cristina Gasparetto,Tomer Mark,Yago Nieto,Shaji Kumar,Parameswaran Hari

Revised International Staging System Is Predictive and Prognostic for Early Relapse (<24 months) after Autologous Transplantation for Newly Diagnosed Multiple Myeloma

2019

Abstract The revised International Staging System (R-ISS) combines ISS with genetic markers and lactate dehydrogenase and can prognosticate newly diagnosed multiple myeloma (MM). Early relapse ( P

Keywords:

Immunology
Lactate dehydrogenase
Early Relapse
Oncology
Diabetes mellitus
Transplantation
Stage (cooking)
Internal medicine
Medicine
Multiple myeloma
autologous transplantation
staging system
newly diagnosed

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations